ucb sa (UCB:EN Brussels)
Transactions by UCB SA (UCB) in the last 6 months
Lannett Company, Inc. (NYSE:LCI) signed a definitive agreement to acquire Kremers Urban Pharmaceuticals Inc. from UCB S.A. (ENXTBR:UCB) for approximately $1.2 billion in cash on September 2, 2015. Lannett will also make post-closing contingent value payments to UCB for each year from 2016 through and including 2020, contingent upon Kremers obtaining an AB rating for its methylphenidate hydrochloride extended release product from the United States Food and Drug Administration. ...
UCB S.A. announced that it will receive $787,628 in an equity round of funding on April 8, 2015. The company will issue securities pursuant to exemption provided under Regulation D.
|Actelion Ltd||SFr.131.90 CHF||-1.60|
|Endo International PLC||$73.00 USD||-1.46|
|Grifols SA||€37.05 EUR||-0.255|
|Sigma-Aldrich Corp||$139.46 USD||-0.10|
|View Industry Companies|